Crystal structure of a hydrophobic 19

Crystal structure of a hydrophobic 19-residue peptide
helix containing three centrally located D amino acids
Isabella L. Karle*†, Hosahudya N. Gopi‡, and Padmanabhan Balaram‡
*Laboratory for the Structure of Matter, Naval Research Laboratory, Washington, DC 20375-5341; and ‡Molecular Biophysics Unit, Indian Institute of
Science, Bangalore 560 012, India
The design of the synthetic 19-residue peptide Boc-Leu-Aib-ValAla-Leu 5 -Aib-Val- D -Ala- D -Leu-Leu 10 -Val-Phe-Val-Aib- D -Val 15 Leu-Phe-Val-Val-OMe (Aib, ␣-aminoisobutyric acid; OMe, methyl
ester) was intended to produce a crystalline peptide with independent helical and hairpin domains. The design was partially
based on an octapeptide with the same sequence as residues 11–18
above, which was shown to fold into a ␤-hairpin in the crystal.
However, the crystal structure of the present peptide provided a
surprising result. The conformation is the longest characterized
right-handed ␣-helix, with as many as three internal D residues in
the sequence. The completely helical structure was also unexpected, because ␤-branched residues such as Val have a low
propensity for helix formation in proteins. The helical peptides in
the present structure assemble to form hydrophobic channels that
accommodate five toluene molecules per peptide along the length
of the channel. The structural results illustrate the similarity in
energetics between helical and ␤-hairpin conformations for peptides containing Aib residues. The crystallographic parameters
for C107H179N19O22䡠3H2O䡠2.5 toluenes are: space group C2, a ⴝ
34.679(3) Å, b ⴝ 12.866(1) Å, c ⴝ 31.915(3) Å, ␤ ⴝ 96.511(8)°,
V ⴝ 14,148 Å3, Z ⴝ 4, dcalc ⴝ 1.099 g兾cm3, and agreement factor
R1 ⴝ 10.2%.
Table 1. Torsional angles in backbone and side chains in HBH-19
S
tereochemically constrained amino acid residues can be
effectively used to nucleate specific polypeptide secondary
structures like ␣-helices and ␤-hairpins (1). ␣-Aminoisobutyric
acid (Aib) and related ␣, ␣-dialkylamino acid residues have been
used in the design of well characterized polypeptide helices
(2–5). The design of ␤-hairpins is facilitated by the introduction
of centrally positioned D-Pro-Xxx segments into polypeptide
sequences (6–8). Several examples of crystalline ␤-hairpins have
been designed (9–11), and the extension of this design strategy
to the construction of multistranded ␤-sheet structures has been
reported (12–14). The availability of relatively rigid modules of
secondary structures permits the construction of synthetic peptides incorporating multiple structural elements. The crystal
structure determination of the 17-residue peptide Boc-Val-AlaLeu-Aib-Val-Ala-Leu-Gly-Gly-Leu-Phe-Val-D-Pro-Gly-LeuPhe-Val-OMe (OMe, methyl ester) provides an example of both
helical and ␤-strand segments in a designed synthetic sequence
(15). In the Lego set approach to the construction of designed
polypeptides, units of secondary structure may be assembled by
using linking segments of potentially defined conformational
properties. In such an approach, stereochemical control over
polypeptide chain folding may be achieved principally through
local conformational constraints, imposed by nonbonded interactions; the structural stability of the domains is enhanced by
intramolecular hydrogen bonding in the helices and hairpins. In
exploring the Lego set approach to de novo protein design, we
designed and synthesized a 19-residue peptide HBH-19 (Fig. 1),
which was anticipated to have well defined helical and hairpin
domains. The choice of the sequence Boc-Leu-Aib-Val-AlaLeu-Aib-Val-D-Ala-D-Leu-Leu-Val-Phe-Val-Aib-D-Val-LeuPhe-Val-Val-OMe was based on the previously determined
structures of the peptide Boc-Leu-Aib-Val-Ala-Leu-Aib-Val-DAla-D-Leu-Aib-OMe (LAD 10, a right-handed helix terminating
Angle
␾
␸
␻
␹1
␹2
⬘
Cl⫺1
NiCi␣C␤l (␬)
Leu-1
⫺55
⫺36
⫺174
⫺173
⫺166
⫹66
180
Aib-2
Val-3
⫺51
⫺69
⫺42
⫺44
⫺173
180
Ala-4
Leu-5
⫺60
⫺56
⫺44
⫺53
178
⫺174
Aib-6
Val-7
⫺56
⫺60
⫺44
⫺52
179
177
D-Ala-8
D-Leu-9
⫺53
⫺54
⫺45
⫺49
⫺179
180
⫹55
Leu-10
⫺62
⫺42
180
⫺68
Val-11
⫺62
⫺42
178
Phe-12
⫺61
⫺43
179
⫺52
⫺178
177
Val-13
⫺61
⫺50
177
Aib-14
D-Val-15
⫺52
⫺56
⫺49
⫺52
⫺176
⫺178
Leu-16
⫺59
⫺43
Phe-17
⫺81
Val-18
Val-19
⫺65
168
⫺180
168
⫺168
⫹65
⫺61
174
175
178
171
⫹64
⫺169
173
⫺67
⫹77
⫹72
177
168
⫺123
⫹64
176
168
⫺69
170
⫹76
⫺175
169
⫺47
⫺112
⫺8
166
⫺75
⫺68
⫺37
176
⫺96
⫹10
178
165
⫺71
⫹64
⫺62
⫺10
⫺174
⫺99
⫹82
175
147
165
137
in a Schellman motif) (16) and Boc-Leu-Phe-Val-Aib-D-AlaLeu-Phe-Val-OMe (UDA8), which yielded a ␤-hairpin in crystals (17). The structures of the crystallographically characterized
fragments corresponding to residues 1–9 and 11–18 of the
designed sequence are illustrated in Fig. 1. We describe in this
report the crystal structure of HBH-19, which forms a long
continuous right-handed helix encompassing the entire length of
the sequence despite the presence of as many as three D amino
acids, including a centrally placed double-D segment (Fig. 2).
Abbreviations: Boc, t-butoxycarbonyl; OMe, methyl ester; Aib, aminoisobutyric acid (U,
one-letter code) (dimethyl glycine); ␣R, right-handed ␣-helix.
Data deposition: The atomic coordinates have been deposited in the Cambridge Structural
Database, Cambridge Crystallographic Data Centre, www.ccdc.cam.ac.uk (CSD ref. no.
199070).
†To
whom correspondence should be addressed. E-mail: [email protected].
Fig. 1.
(Upper) Sequences of peptides HBH-19, LAD10, and UDA8. (Lower) Molecular conformations in crystals of LAD10 (Left) (16) and UDA8 (Right) (17).
Experimental Methods
Peptide Synthesis. The 19-residue peptide HBH-19 was synthesized by conventional solution phase procedures by using a
fragment condensation strategy. t-Butyloxycarbonyl (Boc) and
methyl ester groups are used for N- and C-terminal protection,
respectively. Peptide couplings were mediated by N,N⬘dicyclohexylcarbodiimide and 1-hydroxybenzotriazole. The final
fragment coupling was achieved by using the segments 1–9 and
10–19. The peptide was purified by medium-pressure liquid
chromatography on a reverse-phase C18 (10–60 ␮m) column,
followed by HPLC on a C18 (5–10 ␮m) column with methanol–
water gradients. The identity of the final peptide was confirmed
by matrix-assisted laser desorption ionization mass spectrometry
[Mobs ⫽ 2,106 Da; Mcalc ⫽ 2,104 Da M⫹ Na⫹] and complete
assignment of the 500-MHz 1H NMR spectrum. Crystallization
attempts from aqueous methanol proved unsuccessful. Crystals
suitable for x-ray diffraction were obtained after dissolving the
peptide in a hot methanol–water–toluene mixture, followed by
slow evaporation at room temperature.
X-Ray Diffraction. A crystal in the form of a wafer, 0.27 ⫻ 0.27 ⫻
0.04 mm in size, was used to collect x-ray diffraction data on a
Bruker (Billerica, MA) charge-coupled device diffractometer by
using a high-intensity rotating anode (Cu radiation) to a preset
limit of 67° for ␪ (0.83-Å resolution). Due to the very weak
reflections at the larger scattering angles and the resulting
uncertainty in the intensity measurements, the experimental
data were limited to a resolution of 1.0 Å. The structure solution
process was not automatic. The inclusion of three D residues in
the 19-residue sequence made the prediction of the overall
conformation of the backbone uncertain. Accordingly, various
models for hairpin turns, 310-helices, and ␣-helices were used in
vector search procedures for rotation and translation of a known
model (18, 19).
A model consisting of an ␣-helical 15-atom fragment from the
central portion of Boc-Val-Ala-Leu-Aib-Val-Ala-Leu-Val-AlaLeu-Aib-Val-Lac-Leu-OMe (20) yielded one turn of an ␣-helix
in HBH-19 after rotation, translation, and partial structure
extension with the use of the tangent formula (21). A slow
accretion of atoms in the structure occurred after each of many
single cycles of tangent formula extension and difference maps,
until 90 atoms were located. During these procedures, the 20
CAO moieties appeared as single elongated peaks. After several
isotropic least-squares refinements, the CAO moieties separated into single peaks for the C and O atoms, and additional
atoms were located at the flexible N and C termini, as well as
some in the flexible side chains of Leu and Phe residues. The
complete 148-atom peptide appeared during anisotropic refinement. After the addition of 179 hydrogen atoms in idealized
positions and three water molecules, R1 was still at 12.5%. Large
voids were present in the crystal in a direction lateral to the
helices. The cross sections of the voids are ⬎10 Å. One toluene
molecule occurring with three of its C atoms on a 2-fold rotation
axis was clearly visible. Another two toluene molecules that were
loosely fitted into spaces between the peptide molecules were
discernable. The C atoms in the three toluene molecules were
restrained to give ideal bond engths of 1.39 Å in the ring and 1.53
Å to the CH3 group. For the crystal with a formula containing
C107H179N19O22䡠3H2O䡠2.5 toluenes, the crystallographic parameters are: space group C2, cell parameters a ⫽ 34.679(3) Å, b ⫽
12.866(1) Å, c ⫽ 31.915(3) Å, ␤ ⫽ 96.511(8)°, V ⫽ 14,148 Å3, Z ⫽
4, dcalc ⫽ 1.099 g兾cm3, final R1 factor ⫽ 10.2%.
Details of data collection, coordinates, bond lengths and
angles, and anisotropic thermal parameters are deposited in the
Cambridge Crystallographic Data Centre, reference no. CCDC
199070.
Fig. 3. Three adjacent antiparallel helical molecules in the crystal. The pair
on the left is related by a 2-fold screw axis, and the pair on the right is related
by a 2-fold rotation axis. Side chains for the D residues are darkened.
residues is compatible with Ramachandran’s original maps
showing the allowed regions of torsional ␾ and ␺ values (4, 22),
for example, where positive ␾ and ␺ values for ␣-helices consisting of L residues are ‘‘partially allowed’’ and, by inference,
negative ␾ and ␺ values for D residues in ␣-helices. Experimental
observations of the incorporation of single D residues in righthanded helical peptides or, conversely, L residues into lefthanded helical segments are available (23, 24). A double D
residue segment in a 13-residue right-handed helix has been
reported in crystals (25). The present structure is an example of
three internal D residues incorporated into a continuous ␣R The
only indication in Table 1 among the values of torsional angles
that D residues are present is the values for the C⬘i–1Ni C␣iC␤i
(␬) angles. The ␬ angle assumes values near ⫹75° for the D
residues rather than near 180°, as is common for the L residues.
Hydrogen bond parameters are listed in Table 2. There are 14
consecutive hydrogen bonds of the 531 type, with N–O distances that range from 2.895 to 3.022 Å, except for N9-O5 (2.865
Å) and N11-O7 (3.093 Å) that may have been mildly disturbed
by the presence of D residues, D-Ala 8, and D-Leu 9. At the C
terminus, one weak 431 type hydrogen may be present. Both the
N19–O16 and H19–O16 distances are long; there is no other
possibility for N19H to participate in a hydrogen bond. Near the
C terminus, N1H makes a direct hydrogen bond to O18a of the
next molecule in the head-to-tail region of the continuous
column of helices. N2H is a donor to a water molecule W1, which
in turn is also a donor to O18a and W2a. W2a is also a donor to
O17a. W2a and W2b (not shown) are related by a 2-fold rotation
axis, and their locations are too close to each other (2.20 Å) for
coexistence. Hence, each location can have only one-half occuD
Fig. 2. The ␣R formed by the 19-residue peptide that contains three D
residues, Boc-LUVALUV-D-A-D-L-LVFVU-D-V-LFVV-OMe. Hydrogen bonds are
indicated by dashed lines. The light-colored segment at the top of the diagram, containing the N17a to C20a fragment, shows the head-to-tail connection between helices that stack into continuous columns.
Results and Discussion
Fig. 2 shows a view of the molecular conformation of HBH-19,
which reveals a complete right-handed ␣-helix (␣R) over the
entire backbone. The backbone and side chain torsion angles and
hydrogen bonds are listed in Tables 1 and 2. Remarkably, despite
the insertion of the doublets of D-Ala-8 and D-Leu-9 and Aib-14
and D-Val-15 into the sequence, the molecule forms an almost
ideal ␣-helix. There is ample space between the atoms in the side
chains of the D residues and atoms in the neighboring side chains
of L residues. The closest intramolecular approach is between
C9D1 of D-Leu-9 and C5D2 of L-Leu-5 at 3.99 Å, well above
minimum values for van der Waals approaches between nonbonded C atoms.
Torsional angles for the backbone and side chains are listed in
Table 1. The average values for residues 1 to 16 are ␾ ⫽ ⫺60°,
⌿ ⫽ ⫺46°, close to the ‘‘classical’’ values of (⫺57°, ⫺47°) for an
␣R formed by L amino acids. For the D residues in the present
molecule, D-Ala 8, D-Leu 9, and D-Val 15, the average ␾, ␺ values
are (⫺54°, ⫺49°). The change in sign for the ␾, ␺ values in the
Table 2. Hydrogen bonds in HBH-19 at R1 ⴝ 0.102
Type
Head-to-tail
Peptide–water
431
431
531
531
531
531
531
531
531
531
531
531
531
531
531
531
431
Water–peptide
Donor
Acceptor
DOA,
Å
HOA,
Å
Angle
CAO䡠䡠䡠N(or O),°
N1
N2
N3
N4
N5
N6
N7
N8
N9
N10
N11
N12
N13
N14
N15
N16
N17
N18
N19
W1
W1
W2
W2
W3
W3
N4
018*
W1
00
01
01
02
03
04
05
06
07
08
09
010
011
012
013
014
016
018*
W2§
017
017¶
O0
O15㛳
W3
2.947
2.914
3.029
3.000
2.943
2.958
3.020
3.022
2.865
2.967
3.093
2.975
3.007
2.986
2.895
2.909
3.022
2.998
3.287‡
2.914
3.097
2.780
2.590
2.856
2.940
3.084
2.12
2.03
2.24
2.54†
2.03
2.09
2.13
2.14
1.98
2.11
2.22
2.10
2.12
2.09
2.05
2.03
2.15
2.22
2.66‡
155
132
119
170
148
155
158
159
155
163
161
157
153
151
156
160
161
108
2.44†
*Symmetry equivalent x, y, ⫺1 ⫹ z
†The donor N4H appears to make a bifurcated hydrogen bond to W3 and O1
with long H to acceptor distances. O1 is also an acceptor for N5H, where
normal DOA and HOA distances prevail.
‡The final hydrogen bond in the helix, N19H䡠 䡠 䡠O16, has long distances for
DOA and HOA. There are no other possibilities for hydrogen bonds with
N19H.
§Symmetry equivalent 1⫺x, y, 1 ⫺z.
¶Symmetry equivalent 1⫺x, y, 2⫺z.
㛳Symmetry equivalent 0.5⫺x, 0.5 ⫹ y, 1 ⫺z.
pancy. W3 forms a hydrogen-bonded bridge between N4 and O0
and, in addition, forms a link to carbonyl oxygen O15b in a lateral
peptide molecule. Finally, O1 is at a transition point between a
short segment of a 310-helix and the long ␣-helical portion. All
of the hydrogen bonds are inside the extended helical column or
three water molecules that link the helices in a head-to-tail
fashion.
The helical columns have a totally hydrophobic surface without any possibility for hydrogen bonds between the columns. Fig.
3 shows three adjacent columns with antiparallel packing. The
pair on the left has numerous van der Waals contacts between
the ends of the side chains with C–C distances of 3.8–3.9 Å,
between the adjacent molecules. For the peptide pair on the
right, there is ample space for cocrystallized solvent molecules
as shown in Fig. 4. Three toluene molecules, T1, T2, and T3, and
their symmetry mates, T2⬘ and T3⬘, fill the hydrophobic space
quite efficiently. There are appropriate van der Waals contacts
between the toluene molecules and the hydrophobic side chains
of the peptide helices with C–C distances ranging from 3.54 to
4.02 Å.
A view into the helices shows the formation of the channel by
four ␣-helices (Fig. 5). The channel is in the shape of a straight
tube but is irregular in cross section. It appears to be continuous
along the c axis direction. The walls of the channel are stabilized
by van der Waals contacts of 3.7–3.8 Å between the phenyl group
of Phe-17 of one helix and atoms C2B and C3G1 of an adjacent
Fig. 4. A view of the toluene channel. The helical peptide molecules are
schematically shown as ribbons. The centroid-to-centroid distance of proximal
aromatic rings is marked. Toluene molecules are labeled T1, -2, and -3. The
numbers 12 and 17 refer to Phe-12 and -17.
helix, as well as similar contacts between C5D1 and C3G2 of
other adjacent helices around the channel. Notably, the toluene
molecules accommodate their orientations to the irregular shape
of the channel. There is no ␲-stacking or distinct T shaped
approaches between the rings of the toluene molecules or with
the rings of the peptide helix (Fig. 4). The only close approaches
are between C3T of T1 and C14T of T2, at 3.66 Å; between C16T
of T2 and C12F of Phe-12, at 3.69 Å; and between C25T of T3
and C17F of Phe-17, at 3.66 Å.
The present example illustrates clearly the surprises that may lie
in store in the area of designer peptides. The octapeptide sequence
in Boc-Leu-Phe-Val-Aib-D-Ala-Leu-Phe-Val-OMe adopted a
␤-hairpin conformation, nucleated by an Aib-D-Ala Type I⬘ ␤-turn,
as anticipated by design (17). In contrast, the closely related
segment -Leu-Phe-Val-Aib-D-Val-Leu-Phe-Val- adopts a right-
Fig. 5. (a) View into four adjacent helical molecules that surround the hydrophobic channel. The b axis is horizontal. The toluene molecules are darkened. (b)
The same view without the toluene molecules.
handed helical conformation in HBH-19. In the peptide Boc-LeuAib-Val-Ala-Leu-Aib-Val-D-Ala-D-Leu-Aib-OMe a right-handed
helix is formed over the segment 1–7, with D-Ala adopting an ␣L
conformation resulting in the formation of helix terminating Schellman motif. Further, a peptide chain reversal stabilized by a CH䡠䡠䡠O
bond was observed at the C terminus (16), a feature also observed
in protein structures (26). Dramatically, the corresponding segment
transforms into a right-handed helix in HBH-19. The energetic
penalty for incorporating D-Ala residues into an ␣R conformation
has been estimated as 1.2 kcal䡠mol⫺1 (27). Presumably, the formation of a continuous hydrogen bond network offsets this disadvantage. Examination of the structure in the vicinity of the D residues
suggests no apparent discomfort in accommodating them in an ␣R
conformation. The crystal structure of HBH-19 has provided a
serendipitous observation of a mode of helix aggregation, which
leads to formation of long hydrophobic channels that traverse the
length of the crystal. The space between the two adjacent helical
columns accommodates a series of five toluene molecules. The
three D residues are not oriented close to the channel, suggesting
that they do not influence the shape of the channel. It is possible
that formation of the channel may be facilitated by aromatic
interactions (28) between Phe-17 and the proximate toluene
molecule.
We thank S. Aravinda for help with generating figures. This research was
funded by a Program Support Grant from the Department of Biotechnology, Government of India (Bangalore, India). The work at the Naval
Research Laboratory was supported by National Institutes of Health
Grant GM30902 and the Office of Naval Research.
1. Venkataraman, J., Shankaramma, S. C. & Balaram, P. (2001) Chem. Rev. 101,
3131–3152.
2. Karle, I. L. & Balaram, P. (1990) Biochemistry 29, 6747–6756.
3. Balaram, P. (1992) Curr. Opin. Struct. Biol. 2, 845–851.
4. Kaul, R & Balaram, P. (1999) Bioorg. Med. Chem. 7, 105–117.
5. Silva, R. A. G., Yasui, S. C., Kubelka, J., Formaggio, F., Toniolo, C. &
Keiderling, T. (2002) Biopolymers 65, 229–243.
6. Awasthi, S. K., Raghothama, S. & Balaram, P. (1995) Biochem. Biophys. Res.
Commun. 216, 375–381.
7. Haque, T. S., Little, J. C. & Gellman, S. H. (1996) J. Am. Chem. Soc. 118,
6975–6985.
8. Gellman, S. H. (1998) Curr. Opin. Chem. Biol. 2, 717–725.
9. Karle, I. L., Awasthi, S. K. & Balaram, P. (1996) Proc. Natl. Acad. Sci. USA.
93, 8189–8193.
10. Das, C., Naganagowda, G. A., Karle, I. L. & Balaram, P. (2001) Biopolymers
58, 335–346.
11. Karle, I. L., Gopi, H. N. & Balaram, P. (2001) Proc. Natl. Acad. Sci. USA 98,
3716–3719.
12. Das, C., Raghothama, S. & Balaram, P. (1998)) J. Am. Chem. Soc. 120, 5812–5813.
13. Das, C. & Balaram, P. (1999) J. Chem. Soc. Chem. Commun. 967–968.
14. Venkataraman, J., Naganagowda, G. A. & Balaram, P. (2002) J. Am. Chem.
Soc. 124, 4987–4994.
15. Karle, I. L., Das, C. & Balaram, P. (2000) Proc. Natl. Acad. Sci. USA 97,
3034–3037.
16. Aravinda, S., Shamala, N., Pramanik, A., Das, C. & Balaram, P. (2000)
Biochem. Biophys. Res. Commun. 273, 933–936.
17. Aravinda, S., Shamala, N., Rajkishore, R., Gopi, H. N. & Balaram, P. (2002)
Angew. Chem. Int. Ed. 48, 3863–3865.
18. Nordman, C. E. & Nakatsu, K. (1963) J. Am. Chem. Soc. 85, 353–354.
19. Egert, E. & Sheldrick, G. M. (1985) Acta Crystallogr. A 41, 262–268.
20. Karle, I. L., Das, C. & Balaram, P. (2001) Biopolymers 59, 276–289.
21. Karle, J. (1968) Acta Crystallogr. B 24, 182–186.
22. Ramachandran, G. S. & Sasisekharan, V. (1968) Adv. Protein Chem. 23,
283–437.
23. Karle, I. L. (2001) Biopolymers Peptide Sci. 60, 351–365.
24. Aravinda, S., Shamala, N., Bandyopadhyay, A. & Balaram, P. (2003) J. Am.
Chem. Soc., in press.
25. Aravinda, S., Shamala, N., Desiraju, S. & Balaram, P. (2002) J. Chem. Soc.
Chem. Commun. 2454–2455.
26. Madan Babu, M., Singh, S. K. & Balaram, P. (2002) J. Mol. Biol. 322, 871–880.
27. Fairman, R., Antony-Cahill, S. J. & DeGrado, W. F. (1992) J. Am. Chem. Soc.
114, 5458–5459.
28. Aravinda, S., Shamala, N., Das, C., Sriranjini, A., Karle, I. L. & Balaram, P.
(2003) J. Am. Chem. Soc. 125, 465–475.